Vascular surgeon Peter Schneider (San Francisco, USA) gives some context to results from the LIFE-BTK trial after they were presented at TCT 2023 (23–26 October, San Francisco), highlighting previous failed trials in the BTK segment.
Vascular surgeon Peter Schneider (San Francisco, USA) gives some context to results from the LIFE-BTK trial after they were presented at TCT 2023 (23–26 October, San Francisco), highlighting previous failed trials in the BTK segment.